Published in Leuk Lymphoma on October 01, 1993
Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9. Blood (2005) 1.11
Large-scale identification of disease genes involved in acute myeloid leukemia. J Virol (2004) 1.02
Cytogenomics of hexavalent chromium (Cr 6+) exposed cells: a comprehensive review. Indian J Med Res (2014) 0.80
MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia. Oncotarget (2014) 0.79
The MYCN Protein in Health and Disease. Genes (Basel) (2017) 0.75
Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis. JCI Insight (2017) 0.75
Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res (1998) 2.60
Spontaneous remission in acute myeloid leukaemia. Br J Haematol (1994) 2.30
Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet (1986) 2.21
The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant (1991) 2.12
Central nervous system disease in childhood acute lymphoblastic leukemia: prognostic factors and results of treatment. Pediatr Hematol Oncol (1992) 1.99
FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res (1992) 1.99
Etiology of aseptic meningitis and encephalitis in an adult population. Neurology (2006) 1.90
Differences in DNA-fingerprints between remission and relapse in childhood acute lymphoblastic leukemia. Leuk Res (1988) 1.67
Detection of Chlamydia trachomatis in clinical specimens by nucleic acid spot hybridization. J Gen Microbiol (1985) 1.59
BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene (1994) 1.59
Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis (1982) 1.56
Central nervous system involvement in patients with rotavirus gastroenteritis. Scand J Infect Dis (1978) 1.46
Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol (2012) 1.40
Measles vaccination after exposure to natural measles. J Pediatr (1978) 1.37
Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J Cell Biol (1995) 1.35
Expression of the herpes simplex virus 1 alpha transinducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice. J Virol (1991) 1.31
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood (1997) 1.30
Serum immunoreactive interleukin-6 and C-reactive protein levels in patients with multiple myeloma at diagnosis. Br J Haematol (1994) 1.16
FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res (1992) 1.13
Cell proteins bind to sites within the 3' noncoding region and the positive-strand leader sequence of measles virus RNA. J Virol (1993) 1.11
Putative tyrosine kinases expressed in K-562 human leukemia cells. Proc Natl Acad Sci U S A (1990) 1.09
Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy. Cancer Res (2000) 1.07
Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo. Clin Exp Immunol (1997) 1.06
Respiratory virus infections during anticancer treatment in children. Pediatr Infect Dis J (1995) 1.05
The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood (1996) 1.03
Semliki Forest virus infects mouse brain endothelial cells and causes blood-brain barrier damage. J Virol (1994) 1.01
Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma: a phase II study. Cancer (2001) 1.00
In vitro establishment of lytic and nonproductive infection by herpes simplex virus type 1 in three-dimensional keratinocyte culture. J Virol (1996) 0.99
Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells. Br J Haematol (1997) 0.98
Induction of platelet-derived growth factor gene expression during megakaryoblastic and monocytic differentiation of human leukemia cell lines. EMBO J (1987) 0.98
Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5. Gene Ther (2011) 0.97
DTP and DTP-inactivated polio vaccines: comparison of adverse reactions and IGG, IGM and IGA antibody responses to DTP. Acta Paediatr Scand (1980) 0.96
Serine hydroxymethyltransferase activity and serine incorporation in leukocytes. Cancer Res (1979) 0.96
Disc degeneration in young gymnasts. A magnetic resonance imaging study. Am J Sports Med (1990) 0.96
Expression of the myc proto-oncogenes in developing human fetal brain. Oncogene (1990) 0.95
[Acidocillin concentration in middle ear exudate]. Antibiotiki (1976) 0.94
Alternative mRNA forms and open reading frames of the max gene. Oncogene (1993) 0.93
Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levels. APMIS (1998) 0.92
Superior treatment results in females with high-risk acute lymphoblastic leukemia in childhood. Acta Paediatr (1992) 0.90
Regulation of platelet-derived growth factor gene expression by transforming growth factor beta and phorbol ester in human leukemia cell lines. Mol Cell Biol (1987) 0.90
Biochemical mechanisms in the Killmann experiment: critique of the deoxyuridine suppression test. J Clin Invest (1980) 0.89
The N-myc proto-oncogene and IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain. J Cell Biol (1989) 0.89
Scholastic achievements of children with brain tumors at the end of comprehensive education: a nationwide, register-based study. Neurology (2007) 0.89
Expression of L-myc and N-myc proto-oncogenes in human leukemias and leukemia cell lines. Blood (1991) 0.88
Expression of tie receptor tyrosine kinase in leukemia cell lines. Leukemia (1993) 0.88
Typing of herpes simplex virus isolates with monoclonal antibodies and by nucleic acid spot hybridization. J Virol Methods (1985) 0.87
Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. Br J Cancer (1996) 0.87
Nurses' knowledge about pharmacological and nonpharmacological pain management in children. J Pain Symptom Manage (1999) 0.86
Effects of alpha-interferon on serum beta-2-microglobulin. Leuk Lymphoma (1996) 0.86
Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis. J Neuroimmunol (1996) 0.86
Autolytic changes of human white matter: an electron microscopic and electrophoretic study. Exp Mol Pathol (1987) 0.86
Acute myelogenous leukaemia with c-myc amplification and double minute chromosomes. Lancet (1985) 0.86
Regression-based reference limits for serum transferrin receptor in children 6 months to 16 years of age. Clin Chem (2001) 0.86
Expression of fibroblast growth factor receptors in human leukemia cells. Cancer Res (1992) 0.85
Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. Med Pediatr Oncol (1995) 0.85
Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer (1992) 0.85
Interaction between dopamine and phospholipids. Studies of the substantia nigra in Parkinson disease patients. Arch Neurol (1975) 0.85
Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis. Gene Ther (2001) 0.85
Production of an active urokinase by leukemia cells: a novel distinction from cell lines of solid tumors. Leuk Res (1988) 0.85
Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group. Br J Haematol (1996) 0.85
Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol. Med Pediatr Oncol (1996) 0.84
The life situation of parents over the first year after their child's cancer diagnosis. Acta Paediatr (2004) 0.84
Blast cell-surface and plasma soluble urokinase receptor in acute leukemia patients: relationship to classification and response to therapy. Thromb Haemost (1999) 0.83
Recovery of blood lymphocytes and serum immunoglobulins after treatment of solid tumors in children. Pediatr Hematol Oncol (1994) 0.83
Salivary defense factors in herpes simplex virus infection. J Dent Res (2002) 0.83
Male reproductive health after childhood cancer. Acta Paediatr (2008) 0.83
Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas. Neuropathol Appl Neurobiol (1999) 0.83
Amifostine protects against early but not late toxic effects of doxorubicin in infant rats. Cancer Res (2001) 0.83
Expression of the L2 and E7 genes of the human papillomavirus type 16 in female genital dysplasias. Am J Pathol (1992) 0.82
Guillan-Barré syndrome. Neurochemical and ultrastructural study. Eur Neurol (1971) 0.81
Differential expression of cytokines (IL-2, IFN-gamma, IL-10) and adhesion molecules (VCAM-1, LFA-1, CD44) between spleen and lymph nodes associates with remission in chronic relapsing experimental autoimmune encephalomyelitis. Scand J Immunol (2002) 0.81
Hypoprothrombinaemia and bleeding during administration of cefamandole and cefoperazone. Report of three cases. Ann Clin Res (1985) 0.81
Inactivated poliovaccine: adverse reactions and antibody responses. Acta Paediatr Scand (1980) 0.80
Type I diabetic pregnancy and subclinical human papillomavirus infection. Clin Infect Dis (1997) 0.80
Detection of human papilloma virus (HPV) DNA in genital biopsy specimens by in situ hybridization with digoxigenin-labeled probes. J Virol Methods (1989) 0.80
Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children. Med Pediatr Oncol (2000) 0.80
Polyamine depletion of cells reduces the infectivity of herpes simplex virus but not the infectivity of Sindbis virus. Life Sci (1988) 0.80
Disturbances in craniofacial morphology in children treated for solid tumors. Oral Oncol (2001) 0.80
The siblings of childhood cancer patients need early support: a follow up study over the first year. Arch Dis Child (2004) 0.80
Factors stimulating collagen synthesis from the livers of hypercholesterolemic rats. Atherosclerosis (1976) 0.80
Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol (1994) 0.80
Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's diseases. Acta Neurol Scand (2010) 0.80
Nursing activities and outcomes of care in the assessment, management, and documentation of children's pain. J Pediatr Nurs (1999) 0.79
Cerebrospinal fluid findings in patients with optic neuritis. Acta Ophthalmol (Copenh) (1975) 0.79
Growth impairment and growth hormone therapy in children treated for malignant brain tumours. Eur J Pediatr (1997) 0.79
p53 gene mutations are rare in patients but common in patient-originating cell lines in multiple myeloma. Scand J Clin Lab Invest (1997) 0.79
Radiotherapy enhanced ototoxicity of cisplatin in children. Acta Otolaryngol Suppl (1997) 0.79
Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia. Cancer (2000) 0.79
Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice. Cell Death Dis (2013) 0.79
Childhood cancer patients at school. Eur J Cancer (2002) 0.79
Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield. Bone Marrow Transplant (1997) 0.79